Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

MSU researcher developing new miniature models to study heart disease and sickle cell anemia

A Mississippi State University researcher is developing new miniature models to better understand the factors that lead to heart disease and sickle cell anemia.

24 Jun 2017

Lipoprotein abnormalities linked to vaso-occlusive events in patients with sickle cell disease

An article published in Experimental Biology and Medicine (Volume 242, Issue 12, June, 2017) links imbalances in lipoprotein metabolism with vaso-occlusive events in patients with sickle cell disease

23 Jun 2017

Survivors of childhood diseases struggle to find care as adults

Rachael Goldring was born with congenital heart disease. Had she been born a few decades earlier, she probably would have died as a baby. Now 24, Goldring is part of a population of patients who present new challenges to a health care system unaccustomed to dealing with survivors of once-fatal conditions.

22 Jun 2017

WHO announces new flagship programs for African region over next two years

The World Health Organization’s Regional Director for Africa announced today four new flagship programs for the region over the next two years, including a major push on adolescent health and the creation of regional emergency hubs.

26 May 2017

Children surviving chronic health conditions may suffer from brain function issues

Survival rates continue to rise for children living with once-fatal chronic pediatric health conditions. But their survival comes at a cost: many experience long-term neurocognitive deficits.

17 May 2017

New study explores safety of exercise in children with sickle cell disease

While regular exercise is known to reduce inflammation over time, it actually increases inflammation in the short term.

16 May 2017

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Sangamo Therapeutics, Inc. and Pfizer Inc. today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.

11 May 2017

MUSC researchers provide first systemic evidence for safe use of tPA in stroke patients with SCD

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, report investigators at the Medical University of South Carolina and elsewhere in the March 2017 issue of Stroke.

12 Apr 2017

Researchers develop robust technique for efficient manufacture of red blood cells

Researchers have generated the first immortalised cell lines which allow more efficient manufacture of red blood cells.

23 Mar 2017

Innovative gene therapy allows complete remission of clinical signs of sickle cell disease

A team led by Pr. Marina Cavazzana conducted at Necker Children's Hospital, AP-HP and the Imagine Institute in October 2014 gene therapy in the context of a phase I clinical trial / II in a patient 13 years with severe sickle cell disease.

2 Mar 2017

Scientists secure NIH grant to test portable blood-adhesion monitor for sickle cell disease patients

Researchers at Case Western Reserve University will use a $2 million grant from the National Institutes of Health to develop and test a small, portable blood-adhesion monitor for sickle cell disease patients.

8 Feb 2017

Researchers explore ins and outs of genome sequencing in newborns

When you have a baby, a nurse or a phlebotomist performs a heel stick to take a few drops of blood from your infant and sends it off to a state lab for a battery of tests.

19 Jan 2017

NIH scientists create Salmonella-infected mouse model to study life-threatening meningitis

National Institutes of Healthscientists have established in mice a way to study potentially life-threatening meningitis caused by Salmonella.

9 Dec 2016

ASGCT seeks to educate public and policy-makers on fundamentals of gene editing

On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.

24 Nov 2016

UT Physicians expands Sickle Cell Center to accommodate growing number of patients

For people living with sickle cell disease, chronic pain becomes an all too familiar part of everyday life. The UT Physicians Comprehensive Sickle Cell Center is working to help change that.

15 Nov 2016

Yale researchers use new gene editing technique to correct mutations that cause thalassemia

A Yale-led research team used a new gene editing strategy to correct mutations that cause thalassemia, a form of anemia.

26 Oct 2016

Study identifies causes and outcomes of severe lead poisoning in children

Although national and local policies have reduced the prevalence of lead poisoning in the United States, severe cases still occur.

19 Oct 2016

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

A team of physicians and laboratory scientists has taken a key step toward a cure for sickle cell disease, using CRISPR-Cas9 gene editing to fix the mutated gene responsible for the disease in stem cells from the blood of affected patients.

12 Oct 2016

African ancestry linked to increased kidney disease risk among Hispanic/Latino adults

African ancestry contributes to the risk of chronic kidney disease among some Hispanic/Latino adults, according to a study co-authored by Loyola University Chicago researchers.

5 Oct 2016

New mobile health app may help manage hydroxyurea treatments in sickle cell patients

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded a 6-year, $4.4 million grant to St. Jude Children's Research Hospital and collaborators to improve the use of prescribed medication by sickle cell patients.

21 Sep 2016

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

MSU researcher developing new miniature models to study heart disease and sickle cell anemia

Lipoprotein abnormalities linked to vaso-occlusive events in patients with sickle cell disease

Survivors of childhood diseases struggle to find care as adults

WHO announces new flagship programs for African region over next two years

Children surviving chronic health conditions may suffer from brain function issues

New study explores safety of exercise in children with sickle cell disease

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

MUSC researchers provide first systemic evidence for safe use of tPA in stroke patients with SCD

Researchers develop robust technique for efficient manufacture of red blood cells

Innovative gene therapy allows complete remission of clinical signs of sickle cell disease

Scientists secure NIH grant to test portable blood-adhesion monitor for sickle cell disease patients

Researchers explore ins and outs of genome sequencing in newborns

NIH scientists create Salmonella-infected mouse model to study life-threatening meningitis

ASGCT seeks to educate public and policy-makers on fundamentals of gene editing

UT Physicians expands Sickle Cell Center to accommodate growing number of patients

Yale researchers use new gene editing technique to correct mutations that cause thalassemia

Study identifies causes and outcomes of severe lead poisoning in children

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

African ancestry linked to increased kidney disease risk among Hispanic/Latino adults

New mobile health app may help manage hydroxyurea treatments in sickle cell patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in